NCT00717418

Efficacy Study of Cyclosporine Ophthalmic Emulsion in Patients With Dry Eye Disease

• Status: Completed
• Phase: —
• Study type: Observational
• Enrollment: 781 (actual)
• Sponsor: Allergan · Industry
• Sex: All
• Age: —
• Healthy volunteers: Not accepted

Summary

This study will evaluate the efficacy of cyclosporine ophthalmic solution vs. other non-prescription treatments in patients with dry eye disease. Patient and physician assessments completed at baseline, at each follow-up visit (follow-up visits are variable as per physician discretion) and at final follow-up visit.

Conditions

• Keratoconjunctivitis Sicca

Interventions

Type	Name	Description
DRUG	cyclosporine ophthalmic emulsion 0.05%, artificial tears	one drop, twice a day in each eye

Timeline

• Start date: 2004-09-01
• Primary completion: 2006-08-01
• Completion: 2008-08-01
• First posted: 2008-07-17
• Last updated: 2012-01-12
• Results posted: 2012-01-12

Locations

1 site across 1 country: United States